We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

375 hedge funds and large institutions have $6.87B invested in Edwards Lifesciences in 2013 Q2 according to their latest regulatory filings, with 375 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

543.89% more ownership

Funds ownership: 0% → 543.89% (+544%)

137% more call options, than puts

Call options by funds: $130M | Put options by funds: $54.7M

Holders
375
Holders Change
+375
Holders Change %
–
% of All Funds
12.24%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
375
Increased
–
Reduced
–
Closed
–
Calls
$130M
Puts
$54.7M
Net Calls
+$74.8M
Net Calls Change
+$74.8M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
301
Scotia Capital
Ontario, Canada
$229K +$242K +20,436 New
WFM
302
Wilmington Funds Management
Delaware
$221K +$233K +19,716 New
PAM
303
PartnerRe Asset Management
Connecticut
$219K +$231K +19,554 New
PSUF
304
People's United Financial
Connecticut
$211K +$223K +18,840 New
EOJOAM
305
E. Ohman J:or Asset Management
Sweden
$202K +$213K +18,000 New
RNS
306
Robert N. Shapiro
$191K +$203K +17,136 New
Walleye Trading
307
Walleye Trading
New York
$169K +$179K +15,132 New
TSW
308
Thompson Siegel & Walmsley
Virginia
$148K +$156K +13,200 New
GT
309
Glenmede Trust
Pennsylvania
$143K +$153K +12,900 New
QBFM
310
QS Batterymarch Financial Management
New York
$141K +$149K +12,588 New
LTFS
311
Ladenburg Thalmann Financial Services
Florida
$122K +$128K +10,854 New
BPBT
312
Boston Private Bank & Trust
Massachusetts
$121K +$128K +10,812 New
OA
313
OFI Advisors
Pennsylvania
$103K +$109K +9,216 New
GLI
314
Guardian Life Insurance
New York
$92K +$97.3K +8,220 New
TRCT
315
Tower Research Capital (TRC)
New York
$87K +$92.2K +7,788 New
BC
316
Bartlett & Co
Ohio
$81K +$85.5K +7,224 New
TC
317
TradeLink Capital
Illinois
$74K +$78.1K +6,600 New
WA
318
WFG Advisors
Texas
$70K +$74.3K +6,276 New
SF
319
Synovus Financial
Georgia
$65K +$68.2K +5,760 New
ST
320
Smithfield Trust
Pennsylvania
$64K +$67.5K +5,700 New
GIS
321
Guardian Investor Services
New York
$62K +$65.8K +5,562 New
OSNBOA
322
Old Second National Bank of Aurora
Illinois
$60K +$63.8K +5,388 New
FNBT
323
FineMark National Bank & Trust
Florida
$58K +$61.4K +5,190 New
PCM
324
Prelude Capital Management
New York
$54K +$56.8K +4,800 New
SSB
325
Sandy Spring Bank
Maryland
$54K +$57.2K +4,836 New
11 12
13
14 15

EW Hedge Fund Activity: Q2 2013 in Review

375 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2013, worth a combined $6.87B.

Buyers outnumbered sellers: 375 funds opened new EW positions and 0 closed out — a net gain of 375 holders — while 0 added to existing stakes and 0 trimmed.

  • 375 institutional investors held Edwards Lifesciences (EW) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $6.87B of Edwards Lifesciences stock for Q2 2013.
  • 375 funds opened new Edwards Lifesciences positions in Q2 2013 and 0 closed out, a net change of +375 holders.

Based on aggregated 13F filings for Q2 2013.